Clinical Trials
3 trialsNCT03011268 2025-05-31
BIOSTOP
Helse Møre og Romsdal HF
Phase NA Completed
NCT03452501 2021-02-23
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients
Hikma Pharmaceuticals LLC
Completed
NCT03348046 2020-03-04
PASSRRA
Hikma Pharmaceuticals LLC
Completed